Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113)-Reference-Cited by-同舟云学术

Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113)

Published:2023-06 Issue: Volume:163 Page:110834
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Guggenberger KV.^ORCID,Bley TA.,Held S.,Keller R.,Flemming S.,Wiegering A.,Germer CT.,Kimmel B.,Kunzmann V.,Hartlapp I.,Anger F.

Funder

Celgene

Julius-Maximilians-Universität Würzburg

Bristol-Myers Squibb Company

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference34 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

2. Optimizing the outcomes of pancreatic cancer surgery;Strobel;Nat. Rev. Clin. Oncol.,2019

3. Resectable pancreatic cancer: who really benefits from resection?;Barugola;Ann. Surg. Oncol.,2009

4. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma;Network,2019

5. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial;Kunzmann;LancetGastroenterol. Hepatol.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography-based vascular burden index as a predictor of vascular resection and pathological vascular invasion in pancreatic cancer with neo-adjuvant chemotherapy;European Journal of Surgical Oncology;2024-09

2. New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy;Medicina;2024-06-28

3. Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer;International Journal of Surgery;2024-03-28

4. Computed tomography and guidelines‐based human–machine fusion model for predicting resectability of the pancreatic cancer;Journal of Gastroenterology and Hepatology;2023-11-13